文献速递妇科

腹腔镜与机器人辅助骶骨阴道固定术的脱垂复发率无差异:一项长期比较研究

No Difference in Prolapse Recurrence Rates Between Laparoscopic and Robotic-Assisted Sacrocolpopexy: A Long-Term Comparison.
PubMed 文献 · J Minim Invasive Gynecol · 2024-12-16

该回顾性队列研究纳入2015年1月至2021年12月间139例患者(腹腔镜组74例、机器人辅助组65例),比较两种骶骨阴道固定术的长期疗效。机器人辅助组手术时间更短(164±37分钟 vs 186±36分钟,p=.001),两组复合成功率无显著差异(89.2% vs 90.8%,p=.757),Kaplan-Meier分析显示两组总体脱垂复发率无显著差异(p=.915)。

要点

  • 腹腔镜组与机器人辅助组复合成功率分别为89.2%与90.8%,无显著差异(p=.757)。
  • 机器人辅助组手术时间较腹腔镜组缩短约20分钟(164±37分钟 vs 186±36分钟,p=.001)。
  • 两组网片暴露率分别为4.1%(3例)与3.1%(2例),失血量无临床重要差异。

核心结论

  • 在近4年随访中,腹腔镜与机器人辅助骶骨阴道固定术的脱垂复发率或网片暴露率无差异。
  • 机器人辅助手术平均节省约20分钟时间,两种术式失血量无临床重要差异。

研究设计与样本

  • 回顾性队列研究,在中国一家三级转诊中心开展。
  • 共纳入139例患者,其中腹腔镜组74例、机器人辅助组65例,手术时间范围为2015年1月至2021年12月。

主要发现

  • 腹腔镜组与机器人辅助组中位随访时间分别为60个月(四分位距39-91)与46个月(四分位距38-73)。
  • 机器人辅助组手术时间短于腹腔镜组(164±37分钟 vs 186±36分钟,p=.001)。
  • 两组失血量分别为76±32.1 mL与87.6±33 mL,无临床重要差异。
  • 网片暴露在腹腔镜组发生3例(4.1%),在机器人辅助组发生2例(3.1%)。
  • 复合成功率在腹腔镜组与机器人辅助组分别为89.2%与90.8%,无显著差异(p=.757);Kaplan-Meier生存分析显示两组总体盆腔器官脱垂复发率无显著差异(p=.915)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the long-term efficacy of conventional laparoscopic sacrocolpopexy with those of robot-assisted laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse. DESIGN: Retrospective cohort study. SETTING: Tertiary referral center in China. PATIENTS: A total of 139 patients -74 having laparoscopic and 65 robotic-assisted sacrocolpopexy between January 2015 and December 2021 were included. INTERVENTIONS: Either laparoscopic or robotic-assisted sacrocolpopexy. MEASUREMENTS AND MAIN RESULTS: The median follow-up times of the laparoscopic group and robotic-assisted group were 60 (interquartile range 39-91) and 46 (interquartile range 38-73) months, respectively. Compared with laparoscopy, the robotic-assisted group had a shorter operative time (164 ± 37 minutes vs 186 ± 36 minutes; p = .001) with no clinically meaningful blood loss between the groups (76 ± 32.1 mL vs 87.6 ± 33 mL). Mesh exposure occurred in 3 patients (4.1%) in the laparoscopic and 2 patients (3.1%) in the robotic-assisted group. The composite success rate did not significantly differ between laparoscopic and robotic-assisted groups (89.2% vs 90.8%, p = .757). Kaplan-Meier survival analysis also revealed no significant differences in the overall rates of recurrent pelvic organ prolapse between the two groups (p = .915). CONCLUSION: There is no difference in the rates of prolapse recurrence or mesh exposure at nearly 4 years between laparoscopic or robotic-assisted sacrocolpopexy. There was an average 20-minute time saving for robotic-assisted procedures, with no clinically important difference in blood loss between the surgical approaches.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Jiang X, Mao M, et al. No Difference in Prolapse Recurrence Rates Between Laparoscopic and Robotic-Assisted Sacrocolpopexy: A Long-Term Comparison. J Minim Invasive Gynecol. 2024. PMID: 39694439. doi:10.1016/j.jmig.2024.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。